Emily Hsu

Associate Antitrust & Competition

New York +1 212 390 4520

Emily Hsu

Practices

Overview

Emily Hsu is an antitrust and competition associate in the New York office of Kirkland & Ellis LLP. She provides antitrust guidance to clients in transactional and merger review processes, including before the Federal Trade Commission and U.S. Department of Justice Antitrust Division. In addition, she advises clients in consumer protection investigations before the Federal Trade Commission.

Butterfly Equity and Orgain on the sale of a majority stake in Orgain to Nestlé Health Science.

EQT Corporation on the $5.2 billion acquisition of Tug Hill’s upstream assets and XcL Midstream’s gathering and processing assets.

Francisco Partners and PayScale on the acquisition of Payfactors.

L Catterton and Beauty Industry Group on the acquisition of BELLAMI Hair.

Media Rights Capital’s joint ventures with Penske Media Corporation.

Oracle Corporation on the $28.3 billion acquisition of Cerner Corporation.

Stone Point Capital and CoreLogic on the acquisition of ClosingCorp.

Confidential FTC investigations into companies in the technology and pharmaceutical sectors.

InternFederal Communications CommissionSummer 2018 & Spring 2019

More

Thought Leadership

Publications

Co-author, “Populist Instincts: A Trump Administration Antitrust Merger Retrospective,” Antitrust Magazine, Volume 35 No. 3 (Summer 2021).

Author, “Repatriation as Restitution: Toward Procedural Rights for Indigenous Claims to Moveable Cultural Property,” The George Washington International Law Review, Volume 52 No. 3 (2020).

Credentials

Admissions & Qualifications

  • New York

Education

  • The George Washington University Law SchoolJ.D.2020

    Pro Bono Honors Recipient

    Managing Editor, The George Washington International Law Review

  • University of Notre DameB.A., Anthropology & Theology2013